233 related articles for article (PubMed ID: 21217780)
1. c-Met-induced epithelial carcinogenesis is initiated by the serine protease matriptase.
Szabo R; Rasmussen AL; Moyer AB; Kosa P; Schafer JM; Molinolo AA; Gutkind JS; Bugge TH
Oncogene; 2011 Apr; 30(17):2003-16. PubMed ID: 21217780
[TBL] [Abstract][Full Text] [Related]
2. Non-hematopoietic PAR-2 is essential for matriptase-driven pre-malignant progression and potentiation of ras-mediated squamous cell carcinogenesis.
Sales KU; Friis S; Konkel JE; Godiksen S; Hatakeyama M; Hansen KK; Rogatto SR; Szabo R; Vogel LK; Chen W; Gutkind JS; Bugge TH
Oncogene; 2015 Jan; 34(3):346-56. PubMed ID: 24469043
[TBL] [Abstract][Full Text] [Related]
3. Targeting matriptase in breast cancer abrogates tumour progression via impairment of stromal-epithelial growth factor signalling.
Zoratti GL; Tanabe LM; Varela FA; Murray AS; Bergum C; Colombo É; Lang JE; Molinolo AA; Leduc R; Marsault E; Boerner J; List K
Nat Commun; 2015 Apr; 6():6776. PubMed ID: 25873032
[TBL] [Abstract][Full Text] [Related]
4. Matriptase regulates c-Met mediated proliferation and invasion in inflammatory breast cancer.
Zoratti GL; Tanabe LM; Hyland TE; Duhaime MJ; Colombo É; Leduc R; Marsault E; Johnson MD; Lin CY; Boerner J; Lang JE; List K
Oncotarget; 2016 Sep; 7(36):58162-58173. PubMed ID: 27528224
[TBL] [Abstract][Full Text] [Related]
5. Matriptase is required for the active form of hepatocyte growth factor induced Met, focal adhesion kinase and protein kinase B activation on neural stem/progenitor cell motility.
Fang JD; Lee SL
Biochim Biophys Acta; 2014 Jul; 1843(7):1285-94. PubMed ID: 24685580
[TBL] [Abstract][Full Text] [Related]
6. The multisubstrate adapter Gab1 regulates hepatocyte growth factor (scatter factor)-c-Met signaling for cell survival and DNA repair.
Fan S; Ma YX; Gao M; Yuan RQ; Meng Q; Goldberg ID; Rosen EM
Mol Cell Biol; 2001 Aug; 21(15):4968-84. PubMed ID: 11438654
[TBL] [Abstract][Full Text] [Related]
7. MET signaling in keratinocytes activates EGFR and initiates squamous carcinogenesis.
Cataisson C; Michalowski AM; Shibuya K; Ryscavage A; Klosterman M; Wright L; Dubois W; Liu F; Zhuang A; Rodrigues KB; Hoover S; Dwyer J; Simpson MR; Merlino G; Yuspa SH
Sci Signal; 2016 Jun; 9(433):ra62. PubMed ID: 27330189
[TBL] [Abstract][Full Text] [Related]
8. Matriptase expression and zymogen activation in human pilosebaceous unit.
Wu BY; Lee SP; Hsiao HC; Chiu H; Chen CY; Yeo YH; Lee HS; Chen YW; Kaul M; Kataoka H; Johnson MD; Wang JK; Lin CY
J Histochem Cytochem; 2014 Jan; 62(1):50-9. PubMed ID: 24004857
[TBL] [Abstract][Full Text] [Related]
9. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway.
Chen QY; Jiao DM; Wu YQ; Chen J; Wang J; Tang XL; Mou H; Hu HZ; Song J; Yan J; Wu LJ; Chen J; Wang Z
Oncotarget; 2016 Apr; 7(14):18247-61. PubMed ID: 26919096
[TBL] [Abstract][Full Text] [Related]
10. Endocytic activation and exosomal secretion of matriptase stimulate the second wave of EGF signaling to promote skin and breast cancer invasion.
Ye F; Yuan Z; Tang Y; Li J; Liu X; Sun X; Chen S; Ye X; Zeng Z; Zhang XK; Zhou H
Cell Rep; 2024 Apr; 43(4):114002. PubMed ID: 38547126
[TBL] [Abstract][Full Text] [Related]
11. HGF and c-Met participate in paracrine tumorigenic pathways in head and neck squamous cell cancer.
Knowles LM; Stabile LP; Egloff AM; Rothstein ME; Thomas SM; Gubish CT; Lerner EC; Seethala RR; Suzuki S; Quesnelle KM; Morgan S; Ferris RL; Grandis JR; Siegfried JM
Clin Cancer Res; 2009 Jun; 15(11):3740-50. PubMed ID: 19470725
[TBL] [Abstract][Full Text] [Related]
12. FoxM1 promotes epithelial-mesenchymal transition, invasion, and migration of tongue squamous cell carcinoma cells through a c-Met/AKT-dependent positive feedback loop.
Yang H; Wen L; Wen M; Liu T; Zhao L; Wu B; Yun Y; Liu W; Wang H; Wang Y; Wen N
Anticancer Drugs; 2018 Mar; 29(3):216-226. PubMed ID: 29360662
[TBL] [Abstract][Full Text] [Related]
13. Deregulated matriptase causes ras-independent multistage carcinogenesis and promotes ras-mediated malignant transformation.
List K; Szabo R; Molinolo A; Sriuranpong V; Redeye V; Murdock T; Burke B; Nielsen BS; Gutkind JS; Bugge TH
Genes Dev; 2005 Aug; 19(16):1934-50. PubMed ID: 16103220
[TBL] [Abstract][Full Text] [Related]
14. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma.
Dong G; Chen Z; Li ZY; Yeh NT; Bancroft CC; Van Waes C
Cancer Res; 2001 Aug; 61(15):5911-8. PubMed ID: 11479233
[TBL] [Abstract][Full Text] [Related]
15. Detection of MET oncogene/hepatocyte growth factor receptor in lymph node metastases from head and neck squamous cell carcinomas.
Galeazzi E; Olivero M; Gervasio FC; De Stefani A; Valente G; Comoglio PM; Di Renzo MF; Cortesina G
Eur Arch Otorhinolaryngol; 1997; 254 Suppl 1():S138-43. PubMed ID: 9065649
[TBL] [Abstract][Full Text] [Related]
16. Tissue microarray analysis of hepatocyte growth factor/Met pathway components reveals a role for Met, matriptase, and hepatocyte growth factor activator inhibitor 1 in the progression of node-negative breast cancer.
Kang JY; Dolled-Filhart M; Ocal IT; Singh B; Lin CY; Dickson RB; Rimm DL; Camp RL
Cancer Res; 2003 Mar; 63(5):1101-5. PubMed ID: 12615728
[TBL] [Abstract][Full Text] [Related]
17. In vitro inhibition of matriptase prevents invasive growth of cell lines of prostate and colon carcinoma.
Förbs D; Thiel S; Stella MC; Stürzebecher A; Schweinitz A; Steinmetzer T; Stürzebecher J; Uhland K
Int J Oncol; 2005 Oct; 27(4):1061-70. PubMed ID: 16142324
[TBL] [Abstract][Full Text] [Related]
18. Roles of the HGF/Met signaling in head and neck squamous cell carcinoma: Focus on tumor immunity (Review).
Liu D; Zhong M; Zhan D; Zhang Y; Liu S
Oncol Rep; 2020 Dec; 44(6):2337-2344. PubMed ID: 33125120
[TBL] [Abstract][Full Text] [Related]
19. Matriptase-Induced Phosphorylation of MET is Significantly Associated with Poor Prognosis in Invasive Bladder Cancer; an Immunohistochemical Analysis.
Yamasaki K; Mukai S; Nagai T; Nakahara K; Fujii M; Terada N; Ohno A; Sato Y; Toda Y; Kataoka H; Kamoto T
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30469509
[TBL] [Abstract][Full Text] [Related]
20. Potent and specific inhibition of the biological activity of the type-II transmembrane serine protease matriptase by the cyclic microprotein MCoTI-II.
Gray K; Elghadban S; Thongyoo P; Owen KA; Szabo R; Bugge TH; Tate EW; Leatherbarrow RJ; Ellis V
Thromb Haemost; 2014 Aug; 112(2):402-11. PubMed ID: 24696092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]